Takeda Pharmaceutical Co. TAK

18.86 0.27 1.45% as of 25 Sep
Market cap
$59.2B
P/E
28.4×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Cash and Short Term Investments
4,203.82 2,676.89 3,262.93 4,097.41 7,787.50 9,426.51 6,011.61 6,528.32 3,376.51 3,498.08
Receivables
5,783.90 4,786.68 4,813.51 5,044.53 6,446.96 7,639.51 7,221.27 6,742.07 3,859.13 4,136.44
Inventory
9,217.69 8,034.50 8,348.10 7,299.78 7,593.19 7,086.48 6,988.31 8,880.70 1,916.50 2,104.53
Other current assets
1,191.91 1,141.80 1,229.66 1,303.16 1,255.78 1,348.69 2,497.58 5,304.83 557.14 1,985.09
Total current assets
20,397.32 16,639.87 17,654.20 17,744.88 23,083.41 25,501.19 22,718.77 27,455.92 9,709.27 11,724.16
Property, Plant, Equpment (Net)
13,996.22 12,990.18 13,729.46 12,515.09 14,086.92 13,666.82 12,754.60 11,848.78 4,831.21 4,930.41
Long-Term Investments
2,961.66 2,388.71 2,971.20 2,803.54 2,938.18 3,274.49 3,398.99 2,762.09 2,739.47 2,906.68
Goodwill and Intangible Assets (Total)
60,907.16 59,109.54 66,824.77 67,046.81 73,214.01 74,664.42 75,291.78 81,195.94 18,391.61 19,423.48
Long Term Assets (Tax, Deferred)
3,605.32 2,446.92 2,717.67 2,708.42 3,226.60 3,325.43 2,834.54 800.92 584.82 1,106.40
Long-term assets (Other)
508.27 463.86 353.38 468.61 735.24 943.21 955.38 787.25 701.79 417.66
Total non-current assets
81,978.63 77,399.20 86,596.47 85,542.48 94,200.94 95,874.37 95,235.30 97,394.98 27,248.90 28,784.63
Total Assets
102,375.90 94,039.07 104,250.70 103,287.40 117,284.40 121,375.60 117,954.10 124,850.90 36,958.17 40,508.77
Accounts Payable
3,242.88 3,138.57 3,777.90 4,804.32 4,595.04 3,232.08 2,933.11 2,946.55 2,162.33 2,237.79
Current Part of Debt
3,380.24 3,623.00 2,534.03 2,513.04 1,815.54 208.24 5,398.72 8,864.51 0.16 5,068.76
Current Part of Taxes to Pay
646.01 881.08 758.35 1,719.59 1,788.17 1,364.91 1,681.19 1,075.37 609.25 656.43
Other current liabilities
11,422.56 8,900.38 8,890.13 9,329.40 10,898.25 11,862.63 10,005.25 9,711.95 3,865.84 4,741.66
Total current liabilities
18,691.69 16,543.04 15,960.41 18,366.36 19,097.00 16,667.85 20,018.26 22,598.38 6,637.58 12,704.65
Long Term Debt (Total)
28,839.89 26,177.75 30,887.86 29,916.28 36,858.62 43,364.25 41,459.68 42,894.05 8,870.80 5,578.72
Pension and Post-Retirement Liabilities
948.31 893.83 992.79 944.20 1,298.04 1,493.26 1,440.88 1,408.62 788.50 752.39
Long Term Tax Liability (Deferred)
176.91 232.01 785.06 2,002.59 4,018.45 5,102.81 6,533.35 7,803.55 816.53 1,535.97
Non-current Liabilities (Other)
4,676.87 4,414.98 5,433.92 5,033.37 5,428.91 6,081.92 5,009.02 3,674.02 1,688.09 1,811.69
Total non-current liabilities
34,641.98 31,718.57 38,099.63 37,896.43 47,604.02 56,042.24 54,442.93 55,780.23 12,163.91 9,678.76
Total liabilities
53,333.66 48,261.61 54,060.04 56,262.78 66,701.01 72,710.09 74,461.20 78,378.61 18,801.49 22,383.41
Additional Paid In Capital
11,723.92 11,719.71 12,057.16 12,793.34 15,208.97 15,871.19 15,458.64 14,852.09 816.66 697.24
Common Stock (Net)
11,188.83 11,184.92 11,568.51 12,404.95 14,918.74 15,680.56 15,346.73 14,792.26 701.23 606.39
Retained Earnings
4,701.72 7,838.07 9,599.30 11,404.48 13,169.47 14,193.12 12,603.74 14,124.29 14,015.76 14,059.90
Treasury Stock
324.24 493.78 353.69 742.35 1,032.46 559.79 804.66 514.28 669.36 453.23
Shareholders Equity (Other)
21,744.09 15,522.64 17,314.24 11,160.08 8,314.14 3,441.47 851.59 3,181.88 3,112.52 2,706.32
Common Equity (Total)
49,042.29 45,777.46 50,190.63 47,024.57 50,583.35 48,665.46 43,492.87 46,472.29 18,156.68 18,125.37
Shareholders Equity (Total)
49,042.29 45,777.46 50,190.63 47,024.57 50,583.36 48,665.46 43,492.87 46,472.29 18,156.68 18,125.38
Shareholders Equity and Liabilities (Total)
102,375.90 94,039.07 104,250.70 103,287.40 117,284.40 121,375.60 117,954.10 124,850.90 36,958.17 40,508.77
Shares (Common)
3,159.67 3,147.30 3,138.03 3,109.06 3,100.72 3,126.72 3,115.53 3,130.01 1,562.62 1,561.68
Shareholders Equity (Tangible)
(11,864.89) (13,332.07) (16,634.14) (20,022.24) (22,630.66) (25,998.96) (31,798.91) (34,723.65) (234.93) (1,298.11)
Net Debt
28,016.31 27,123.86 30,158.96 28,331.91 30,886.66 34,145.98 40,846.79 45,230.24 5,494.45 7,149.39
Total Debt
32,220.13 29,800.75 33,421.89 32,429.32 38,674.16 43,572.49 46,858.40 51,758.56 8,870.96 10,647.48

Fold the line items

In millions of $ except per-share values · columns are period end dates